Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Vaccine Technologies Market?

The market size of vaccine technologies has seen a swift expansion in the past few years. The market value is projected to rise from $55.59 billion in 2024 to $61.38 billion in 2025, maintaining a compound annual growth rate (CAGR) of 10.4%. The market’s surge during the historic period is due to increased cases of infectious diseases, enhanced government support for vaccine research, the eruption of pandemics, rising consciousness on vaccine advantages, and the broadening of immunization initiatives.

Rapid expansion is anticipated in the vaccine technologies market size in the coming years. It’s projected to reach $90.17 billion in 2029, with a compound annual growth rate (CAGR) of 10.1%. The escalation in the anticipation period is linked to the augmenting demand for mRNA vaccines, escalating investments in personalized vaccines, increasing concentration on cancer vaccines, a higher incidence of chronic diseases, and enhanced consciousness about vaccine safety. Major trends that are expected during the anticipation period are the formulation of mRNA and DNA-based vaccines, expansion of nanoparticle vaccine delivery systems, rise in combination vaccines, growing preference for thermostable vaccines, and the emphasis on needle-free vaccine delivery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24735&type=smp

Which Factor Is Shaping The Future Of The Vaccine Technologies Market?

The escalation in the count of transmissible diseases is anticipated to surge the advancement of the vaccine technologies market. Transmissible illnesses are inflicted by harmful microorganisms such as bacteria, viruses, fungi and parasites, which can be passed on directly or indirectly from person to person. The augmenting rate of such diseases owes to amplified travel, enabling pathogens to be transported swiftly across borders. Vaccine technologies contribute towards the treatment of infectious diseases by promoting targeted immune responses, thereby aiding in prevention and control of infections. These technologies bolster public health initiatives by curbing disease progression and intensity, thereby enhancing healthcare outcomes overall. For instance, the UK Health Security Agency, a government agency of the UK, reported in February 2024 that the instances of tuberculosis (a contagious bacterial disease that mainly impacts the lungs) in England climbed to 4,850 in 2023, a hike of 10.7% from 4,380 cases in 2022. Hence, the swell in the frequency of infectious diseases is fueling the expansion of the vaccine technologies market.

What Is The Segment-Wise Breakdown Of The Vaccine Technologies Market?

The vaccine technologies market covered in this report is segmented –

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

2) By Route Of Administration: Parenteral, Oral, Nasal

3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases

4) By Age Group: Pediatric, Adults

5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

Which Trends Are Redefining The Future Landscape Of The Vaccine Technologies Industry?

Leading firms in the vaccine technologies market are concentrating on creating innovative solutions like quadrivalent influenza vaccines, to widen the scope of immunization coverage and decrease the likelihood of strain mismatch. Quadrivalent influenza vaccines are designed to shield from four strains of influenza virus, including two influenza A and two influenza B viruses, providing more extensive protection than trivalent vaccines. For example, Zydus Lifesciences, a pharmaceutical company based in India, rolled out VaxiFlu-4, a quadrivalent influenza vaccine, in February 2025. This vaccine provides seasonal defense against four influenza strains, covering both influenza A and B types. The vaccine, which is administered as a single-dose intramuscular injection, is appropriate for both adults and children. It significantly mitigates the impact of seasonal influenza by providing wider strain coverage than conventional trivalent vaccines.

Which Companies Hold The Largest Market Share In The Vaccine Technologies Sector?

Major companies operating in the vaccine technologies market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Moderna Inc., CSL Limited, Bharat Biotech International Limited, Bavarian Nordic A/S, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd., Emergent BioSolutions Inc., Valneva SE, Novavax Inc., Dynavax Technologies Corporation, CureVac N.V., Inovio Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

How Does Regional Performance Compare Across The Vaccine Technologies Industry?

North America was the largest region in the vaccine technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24735&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model